Have a personal or library account? Click to login

Hepatitis C and bleeding disorders in Europe

The Journal of Haemophilia Practice
Volume 5 (2018): Issue 1 (April 2018)
By:
Open Access
|Jun 2018

References

  1. Makris M, Konkle BA. Hepatitis C in haemophilia: time for treatment for all. Haemophilia 2017; 23(2): 180-1. doi:10.1111/ hae.13183.
    Open DOISearch in Google ScholarBack to article
  2. Evatt BL. The tragic history of AIDS in the hemophilia population. 1982-1984. J Thromb Haemost 2006; 4(11): 2295301. doi 10.1111/j.1538-7836.2006.02213.x.
    Open DOISearch in Google ScholarBack to article
  3. O’Mahony B, Noone D, Giangrande PLF, Prihodova L. Haemophilia care in Europe – a survey of 35 countries. Haemophilia 2013; 19(4): e239-47. doi:10.1111/hae.12125.
    Open DOISearch in Google ScholarBack to article
  4. World Federation of Hemophilia. Report on the Annual Global Survey 2014 2015. Available from http://www1.wfh.org/publications/files/pdf-1627.pdf (accessed 13 March 2018).
    Search in Google ScholarBack to article
  5. Lee YA, Friedman SL. Reversal, maintenance or progression: what happens to the liver after a virologic cure of hepatitis C? Antiviral Res 2014; 107: 23-30. doi:10.1016/j. antiviral.2014.03.012.
    Open DOISearch in Google ScholarBack to article
  6. Persico M, Rosato V, Aglitti A, et al. Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis. Antivir Ther 2017. doi:10.3851/IMP3186. [Epub ahead of print].
    Open DOISearch in Google ScholarBack to article
  7. El Sherif O, Afhdal N, Curry M. No one size fits all-Shortening duration of therapy with direct-acting antivirals for hepatitis C genotype 1 infection. J Viral Hepat 2017; 24(10): 808-13. doi:10.1111/jvh.12734.
    Open DOISearch in Google ScholarBack to article
  8. Posthouwer D, Plug I, van der Bom JG, et al. Hepatitis C and health-related quality of life among patients with hemophilia. Haematologica 2005; 90(6): 846-50.
    Search in Google ScholarBack to article
  9. Health Protection Surveillance Centre, Ireland. National Hepatitis C Database for infection acquired through blood and blood products: 2015 Report. [2015] Available from https://www.hpsc.ie/a-z/hepatitis/hepatitisc/hepatitiscdatabase/baselineandfollow-upreports/File,15238,en.pdf (accessed 13 March 2018).
    Search in Google ScholarBack to article
  10. Lövdahl S, Henriksson KM, Baghaei F, et al. Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden. Haemophilia 2013;19(3): 362-9. doi:10.1111/hae.12092.
    Open DOISearch in Google ScholarBack to article
  11. Posthouwer D, Plug I, van der Bom JG, et al. Hepatitis C infection among Dutch haemophilia patients: a nationwide cross-sectional study of prevalence and antiviral treatment. Haemophilia 2005; 11(3): 270-5. doi:10.1111/j.1365-2516.2005.01083.x.
    Open DOISearch in Google ScholarBack to article
  12. Ebeling F, Rasi V, Laitinen H, Krusius T. Viral markers and use of factor products among Finnish patients with bleeding disorders. Haemophilia 2001; 7(1): 42-6.
    Search in Google ScholarBack to article
  13. Irish Haemophilia Society celebrates eradication of Hepatitis C among members. Irish Examiner 22 December 2016. Available from https://www.irishexaminer.com/breakingnews/ireland/irish-haemophilia-society-celebrates-eradication-of-hepatitis-c-among-members-769660.html (accessed 13 March 2018).
    Search in Google ScholarBack to article
  14. Cortez-Pinto H. National HCV programmes: a European approach to eliminating hepatitis C. Presentation delivered at the European Haemophilia Consortium Round Table of Stakeholders: HCV and Haemophilia, Brussels, June 2016. Available from https://static.ehc.eu/wp-content/uploads/09-EHC-June-RT-Presentation-Cortez-Pinto-FOR-DISTRIBUTION.pdf (accessed 14 May 2018).
    Search in Google ScholarBack to article
  15. Graham K. Portugal agrees to treat 13,000 Hepatitis C sufferers for free. Digital Journal 8 Feb 2015. Available from http://www.digitaljournal.com/life/health/portugal-agrees-to-treat-13-000-hepatitis-c-sufferers-for-free/article/425590 (accessed 13 March 2018).
    Search in Google ScholarBack to article
  16. Giangrande PLF, Peyvandi F, O’Mahony B, et al. Kreuth IV: European consensus proposals for treatment of haemophilia with coagulation factor concentrates. Haemophilia 2017; 23(3): 370-5. doi:10.1111/hae.13211.
    Open DOISearch in Google ScholarBack to article
  17. Kattakuzhy S, Gross C, Emmanuel B, et al. Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers. Ann Intern Med 2017; 167(5): 311-8. doi:10.7326/M17-0118.
    Open DOISearch in Google ScholarBack to article
  18. Nyalakonda H, Utay NS. A new era of therapy for hepatitis C virus infection. Curr Opin Infect Di. 2015; 28(5): 471-8. doi:10.1097/QCO.0000000000000190.
    Open DOISearch in Google ScholarBack to article
  19. Cousins S. The Tasmanian Hep C Buyers’ Club. New York Times 25 July 2017. Available from https://www.nytimes.com/2017/07/25/opinion/the-tasmanian-hep-c-buyers-club.html (accessed 13 March 2018).
    Search in Google ScholarBack to article
DOI: https://doi.org/10.17225/jhp00112 | Journal eISSN: 2055-3390
Journal RSS Feed
Language: English
Page range: 50 - 65
Published on: Jun 28, 2018
Published by: Haemnet Ltd
In partnership with: Paradigm Publishing Services
Publication frequency: 1 times per year
Keywords:
Bleeding disorders,
Haemophilia,
Hepatitis C,
Monitoring,
Treatment
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Clinical medicine, other,
Pharmacy,
Pharmacology

© 2018 Laura Savini, Radoslaw Kaczmarek, Declan Noone, Paul Giangrande, Geoffrey Dusheiko, Brian O’Mahony, published by Haemnet Ltd
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 5 (2018): Issue 1 (April 2018)Next article